five

Identification of genes associated resistance of everolimus in cutaneous squamous cell carcinoma

收藏
NIAID Data Ecosystem2026-03-11 收录
下载链接:
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112079
下载链接
链接失效反馈
官方服务:
资源简介:
Metastatic squamous cell carcinoma suggest mTOR inhibitor as therapeutic agent because of activation of the PI3K/AKT/mTOR pathway. However, many therapeutic agents about cancer show resistance. Here, we investigated resistance network about mTOR inhibitor in skin squamous cell carcinoma using microarray. Our study identified that CCND1 overexpression increase resistance about mTOR inhibitor. The molecular mechanism may improve in therapeutic effects of mTOR inhibitor in cutaneous SCC. Total RNA obtained from cells A431 and HSC-1 treated with DMSO or 100nM everolimus for 72h
创建时间:
2019-03-15
二维码
社区交流群
二维码
科研交流群
商业服务